Piper Sandler lowered the firm’s price target on UnitedHealth (UNH) to $600 from $605 and keeps an Overweight rating on the shares. The firm revised its model to conform with the company’s 2025 guidance. If UnitedHealth’s Q4 results meet consensus estimates, the company will have delivered 12.8% adjusted annual earnings growth from 2019 to 2024, the analyst tells investors in a research note. Over the next six years, Piper expects the company to continue to execute against its 13%-16% long-term earnings growth target.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- Dow Jones 2024 Wrap-Up: December Drops Don’t Stop Annual Gains
- 5 “Strong Buy” Healthcare Stocks to Buy Before They Soar in 2025
- UnitedHealth doctors helped it collect billions from Medicare, WSJ says
- Netflix draws big viewership for NFL Christmas games: Morning Buzz
- Morning Movers: Arena climbs after NYSE acceptance of plan to regain compliance